Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6652 stock hub

TPEX/6652 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6652is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
268.5M
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6652
In the news

Latest news · TPEX/6652

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-11.5
P25 -16.2P50 0.3P75 9.8
ROIC-116.4
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6652 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
158
Groups with data
10
Currency
TWD
Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Taiwan
Country code
TW
Employees
39
Employees Change
2%
Employees Change Percent
5.41
Enterprise value
TWD -21M
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0006652001
Last refreshed
2026-05-10
Market cap
TWD 268.5M
Price
TWD 1.96
Price currency
TWD
Sector
Healthcare
Sic
2836
Symbol
tpex/6652
Website
https://www.eusol-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-15.05%
EV Earnings
0.52x
EV/FCF
0.6x
FCF yield
-13.03%
P/B ratio
0.81x
P/S ratio
129.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
Gross margin
32.16%
Gross Profit
TWD 668,000
Gross Profit Growth
242.56%
Net Income
TWD -40.4M
Net Income Growth Years
0%
Pretax Margin
-1,945.88%
ROA
-8.09
Roa5y
-10.45
ROCE
-13.89
ROE
-11.54
Roe5y
-14.36
ROIC
-116.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
-67.57%
Cagr3y
-47.37%
Cagr5y
-39.93%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
TWD 0.01
Assets
TWD 349.4M
Cash
TWD 300.8M
Current Assets
TWD 328.2M
Current Liabilities
TWD 10.4M
Debt
TWD 11.3M
Debt Equity
TWD 0.03
Debt FCF
TWD -0.32
Equity
TWD 330M
Interest Coverage
-359.5
Liabilities
TWD 19.4M
Long Term Assets
TWD 21.2M
Long Term Liabilities
TWD 9M
Net Cash
TWD 289.6M
Net Cash By Market Cap
TWD 108
Net Cash Growth
-15.47%
Net Debt Equity
TWD -0.88
Tangible Book Value
TWD 329.9M
Tangible Book Value Per Share
TWD 2.41
WACC
3.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
31.59
Inventory Turnover
0.69
Net Working Capital
TWD 19.3M
Quick ratio
31.26
Working Capital
TWD 317.8M
Working Capital Turnover
TWD 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-67.55%
200-day SMA
6.37
3Y total return
-85.43%
50-day SMA
5.8
50-day SMA vs 200-day SMA
50under200
5Y total return
-92.18%
All Time High
54
All Time High Change
-96.37%
All Time High Date
2018-08-29
All Time Low
1.87
All Time Low Change
4.81%
All Time Low Date
2026-04-09
ATR
0.5
Beta
-0.08
Ch YTD
-66.84
High
2.28
High52
10.2
High52 Date
2026-01-26
High52ch
-80.78%
Low
1.87
Low52
1.87
Low52 Date
2026-04-09
Low52ch
4.81%
Ma50ch
-66.21%
Price vs 200-day SMA
-69.23%
RSI
21.53
RSI Monthly
29.14
RSI Weekly
23.52
Sharpe ratio
-0.94x
Sortino ratio
-1.31
Tr YTD
-66.84
Tr1m
-68.89%
Tr1w
-18.33%
Tr3m
-66.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -47.1M
Operating margin
-2,267.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
67,057,163%
Net Borrowing
-2,356,000
Shares Insiders
47.95%
Shares Institutions
2.06%
Shares Out
137,000,000
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
TWD -35M
Average Volume
1,149,797.2x
Bv Per Share
2.41
CAPEX
TWD -2.4M
Ch1m
-68.89
Ch1w
-18.33
Ch1y
-67.55
Ch3m
-66.95
Ch3y
-85.43
Ch5y
-92.18
Ch6m
-75.19
Change
0%
Change From Open
-12.89
Close
1.96
Days Gap
14.8
Depreciation Amortization
812,000
Dollar Volume
14,678,230.3
Earnings Date
2026-05-14
EBIT
TWD -47.1M
EBITDA
TWD -46.3M
EPS
TWD -0.3
F Score
2
FCF
TWD -35M
FCF EV Yield
166.35x
FCF Per Share
TWD -0.26
Financing CF
-2,356,000
Fiscal Year End
December
Founded
1,994
Investing CF
-22,247,000
Is Primary Listing
1
Last Earnings Date
2025-11-07
Last Report Date
2025-12-31
Ma150
6.46
Ma150ch
-69.66%
Ma20
4.2
Ma20ch
-53.32%
Net CF
-57,140,000
Next Earnings Date
2026-05-14
Open
2.25
Position In Range
21.95
Ppne
14,027,000
Price Date
2026-04-09
Ptbv Ratio
0.81
Relative Volume
6.51x
Revenue
2,077,000x
Tr6m
-75.19%
Volume
7,488,893
Z Score
23.21
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/6652 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6652 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-67.5%
S&P 500 1Y: n/a
3Y total return
-85.4%
S&P 500 3Y: n/a
5Y total return
-92.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6652?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.1%
Share of float held by funds and institutions
Insider ownership
+47.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

TPEX/6652 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
21.5
Below 30: short-term oversold
Price vs 200-day MA
-69.2%
50/200-day relationship not available
Beta (5Y)
-0.07
Less volatile than the market
Sharpe ratio
-0.94
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6652

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6652 stock rating?

tpex/6652 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6652 analysis?

The full report lives at /stocks/tpex/6652/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6652?

The latest report frames tpex/6652 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6652 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tpex/6652 stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier